Latest Insider Transactions at Cross Country Healthcare Inc (CCRN)
This section provides a real-time view of insider transactions for Cross Country Healthcare Inc (CCRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CROSS COUNTRY HEALTHCARE INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CROSS COUNTRY HEALTHCARE INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 03
2023
|
Dwayne Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,916
+50.0%
|
-
|
Nov 28
2022
|
Cynthia Ann Grieco VP, Corporate Treasurer |
SELL
Open market or private sale
|
Direct |
1,071
-8.23%
|
$38,556
$36.0 P/Share
|
Nov 16
2022
|
Venkat Bhamidipati Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,850
+50.0%
|
-
|
Oct 03
2022
|
William J. Burns Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,293
-5.78%
|
$1,249,083
$31.0 P/Share
|
Oct 03
2022
|
Susan E Ball General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
14,901
-8.72%
|
$447,030
$30.0 P/Share
|
Sep 19
2022
|
William J. Burns Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,705
-2.86%
|
$411,740
$28.97 P/Share
|
Sep 19
2022
|
Susan E Ball General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
44,357
-7.38%
|
$1,241,996
$28.98 P/Share
|
Aug 30
2022
|
W Larry Cash Director |
BUY
Open market or private purchase
|
Direct |
1,500
+0.84%
|
$37,500
$25.6 P/Share
|
Aug 24
2022
|
John Anthony Martins President, CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+7.14%
|
$100,000
$25.24 P/Share
|
Jun 14
2022
|
Marc S. Krug Group President, Delivery |
SELL
Payment of exercise price or tax liability
|
Direct |
1,138
-2.68%
|
$20,484
$18.07 P/Share
|
Jun 01
2022
|
W Larry Cash Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-1.45%
|
$44,183
$17.36 P/Share
|
Jun 01
2022
|
W Larry Cash Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+3.87%
|
-
|
Jun 01
2022
|
Thomas C Dircks Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+8.91%
|
-
|
Jun 01
2022
|
Gale S Fitzgerald Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+4.31%
|
-
|
Jun 01
2022
|
Janice Elizabeth Nevin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,465
-9.8%
|
$41,905
$17.36 P/Share
|
Jun 01
2022
|
Janice Elizabeth Nevin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+22.26%
|
-
|
Jun 01
2022
|
Darrell S Sr Freeman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,599
-4.07%
|
$44,183
$17.36 P/Share
|
Jun 01
2022
|
Darrell S Sr Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+10.14%
|
-
|
Jun 01
2022
|
Mark C Perlberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+8.22%
|
-
|
Jun 01
2022
|
Kevin Cronin Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,201
+1.25%
|
-
|
May 10
2022
|
Phillip Lyn Noe Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-7.94%
|
$15,312
$16.27 P/Share
|
Apr 18
2022
|
Daniel Joseph White Former Chf. Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,436
+48.34%
|
-
|
Mar 31
2022
|
Phillip Lyn Noe Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,753
+28.29%
|
-
|
Mar 31
2022
|
Susan E Ball General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
19,929
-2.19%
|
$418,509
$21.67 P/Share
|
Mar 31
2022
|
Susan E Ball General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
13,268
+5.34%
|
-
|
Mar 31
2022
|
William J. Burns Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,611
-2.81%
|
$663,831
$21.67 P/Share
|
Mar 31
2022
|
William J. Burns Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,036
+6.11%
|
-
|
Mar 31
2022
|
Kevin Cronin Clark Director |
SELL
Payment of exercise price or tax liability
|
Direct |
114,777
-4.53%
|
$2,410,317
$21.67 P/Share
|
Mar 31
2022
|
Cynthia Ann Grieco VP, Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,036
-2.52%
|
$21,756
$21.67 P/Share
|
Mar 31
2022
|
Cynthia Ann Grieco VP, Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
2,769
+16.46%
|
-
|
Mar 31
2022
|
John Anthony Martins President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-4.38%
|
$46,242
$21.67 P/Share
|
Mar 31
2022
|
John Anthony Martins President, CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,457
+39.97%
|
-
|
Mar 31
2022
|
Colin Patrick Mc Donald Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,975
-2.89%
|
$62,475
$21.67 P/Share
|
Mar 31
2022
|
Colin Patrick Mc Donald Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,462
+11.41%
|
-
|
Mar 31
2022
|
Karen Mote Pres., Cross Country Locums |
SELL
Payment of exercise price or tax liability
|
Direct |
4,836
-3.15%
|
$101,556
$21.67 P/Share
|
Mar 31
2022
|
Karen Mote Pres., Cross Country Locums |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.94%
|
-
|
Mar 31
2022
|
Buffy S White Pres. - Travel Nurse & Allied |
SELL
Payment of exercise price or tax liability
|
Direct |
13,688
-3.97%
|
$287,448
$21.67 P/Share
|
Mar 31
2022
|
Buffy S White Pres. - Travel Nurse & Allied |
BUY
Grant, award, or other acquisition
|
Direct |
8,826
+8.8%
|
-
|
Mar 28
2022
|
Karen Mote Pres., Cross Country Locums |
BUY
Grant, award, or other acquisition
|
Direct |
5,335
+12.53%
|
-
|
Mar 28
2022
|
Buffy S White Pres. - Travel Nurse & Allied |
BUY
Grant, award, or other acquisition
|
Direct |
8,961
+9.78%
|
-
|
Mar 28
2022
|
Colin Patrick Mc Donald Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,414
+12.73%
|
-
|
Mar 28
2022
|
Susan E Ball General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
16,003
+6.73%
|
-
|
Mar 28
2022
|
William J. Burns Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,005
+9.28%
|
-
|
Mar 28
2022
|
Kevin Cronin Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
96,818
+12.51%
|
-
|
Mar 07
2022
|
Susan E Ball General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
17,458
-7.82%
|
$349,160
$20.72 P/Share
|
Mar 07
2022
|
William J. Burns Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.91%
|
$200,000
$20.54 P/Share
|
Dec 28
2021
|
Thomas C Dircks Director |
BUY
Bona fide gift
|
Indirect |
49,265
+50.0%
|
-
|
Dec 28
2021
|
Thomas C Dircks Director |
SELL
Bona fide gift
|
Direct |
49,265
-42.6%
|
-
|
Aug 17
2021
|
William J. Burns Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,100
-3.8%
|
$191,900
$19.91 P/Share
|
Aug 16
2021
|
Joseph Trunfio Director |
SELL
Open market or private sale
|
Direct |
17,000
-27.45%
|
$323,000
$19.52 P/Share
|